Bridging the Gap: Addressing Eating Disorders and Obesity Together
For decades, eating disorders and obesity have been treated as distinct issues, with specialists in each field focusing on different aspects of health. Eating disorder experts typically emphasize psychopathology, body image, and extreme weight-control behaviors, while obesity specialists concentrate on metabolic health, nutrition, and weight management. Although this separation has led to significant advances in both areas, it may also create limitations in treatment and understanding.
In contemporary clinical practice, it is increasingly recognized that patients often do not fit neatly into one category. For instance, binge-eating disorder is commonly seen among individuals seeking treatment for obesity. Conversely, some individuals with obesity may develop restrictive eating disorders, and eating issues can arise after bariatric surgery. Furthermore, those with eating disorders may face obesity-related medical complications, indicating that the boundaries between these two fields are less clear than previously thought.
While it is essential to acknowledge the distinct nature of obesity and eating disorders, they share several important underlying mechanisms. Body dissatisfaction can lead individuals to attempt to change their weight and shape, while rigid dietary restrictions may result in episodes of overeating or binge eating. Emotional regulation difficulties can also impact eating behaviors, and weight stigma can exacerbate psychological distress, influencing both eating and physical activity. These shared experiences are often studied from different perspectives, yet they occur within the same individual. Therefore, fostering collaboration between the two fields could enhance our understanding and treatment of these complex issues.
One immediate benefit of increased collaboration would be improved assessment practices. Individuals seeking treatment for obesity are not always evaluated for eating-disorder psychopathology. Identifying behaviors such as binge eating, extreme dietary restriction, or over-evaluation of shape and weight can significantly influence treatment planning. Conversely, eating disorder clinicians may focus so heavily on psychopathology that they overlook important obesity-related medical risks.
A comprehensive assessment should consider eating behaviors, psychological functioning, physical health, medical complications, and the individual's relationship with body weight and shape. Rather than asking whether a person has an eating disorder or obesity, a more useful question is, "What processes are currently damaging this person's physical and psychosocial health, and how should they be addressed?"
Weight stigma represents a clear area for collaboration. It is associated with psychological distress, body dissatisfaction, disordered eating, social withdrawal, and poorer quality of life. When individuals internalize negative stereotypes about body weight, they may begin to judge themselves by those same standards, undermining their psychological well-being and hindering sustainable health-related changes. Therefore, reducing weight stigma should not be the sole responsibility of either the eating disorder or obesity fields; it is a shared obligation.
The recent introduction of medications like semaglutide and tirzepatide has made these discussions particularly timely. These medications can lead to significant weight loss and improve cardiometabolic health, and emerging research suggests they may also reduce hunger and binge-eating episodes in some individuals. However, it is crucial to recognize that reducing a behavior does not necessarily equate to altering the psychological processes that sustain an eating disorder. For example, a person may experience fewer binge-eating episodes while still placing excessive importance on their weight and shape. Rapid weight loss and positive feedback from others might further intensify this focus, potentially leading to restrictive eating behaviors that may go unrecognized.
These complexities should not be used to argue against effective obesity medications; rather, they highlight the necessity for collaboration between obesity specialists and eating disorder clinicians. Concerns about collaboration are understandable. Eating disorder specialists may fear that an overemphasis on weight loss could exacerbate eating disorder psychopathology, while obesity specialists might worry that neglecting weight discussions could overlook critical medical risks. Both concerns warrant consideration.
Anorexia nervosa, bulimia nervosa, binge-eating disorder, and clinical obesity require different treatment approaches, and specialist expertise remains vital. The goal should be to foster constructive dialogue. Eating disorder clinicians possess valuable insights into dietary restraint, binge eating, and body image, while obesity specialists have extensive knowledge of metabolic health, nutrition, and long-term behavior change. Patients may benefit when these perspectives are integrated rather than viewed as competing.
Ultimately, the distinction between an "eating disorder problem" and an "obesity problem" may be less significant to patients than to professionals. What is crucial is receiving treatment that comprehensively addresses their clinical picture, free from stigma or ideological barriers, while giving equal attention to both psychological and physical health.




